Scholar Commons
metadata only
Association of Nucleoside Reverse Transcriptase Inhibitor Use With Reduced Risk of Alzheimer'S Disease Risk
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Robust transcriptomic signatures of Alzheimer's disease progression: validated explainable AI approach.#213872
- Oligonucleotide-Recognizing Topoisomerase Inhibitors (OTIs): precision gene editors for neurodegenerative diseases?#287221
- Population attributable fractions of modifiable dementia risk factors in the Netherlands: a cross-sectional, time series analysis#311529
- Biomarker-based Trial of NPC-1 for Alzheimer's Pathology#897412
- Characterization and pharmacological modulation of Alzheimers disease-associated human microglial states#1136700
Record · ID 352263
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive